Detailed information for compound 1696313

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 390.521 | Formula: C24H30N4O
  • H donors: 0 H acceptors: 1 LogP: 4.29 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 1
  • SMILES: CN(CCOc1ccc2c(c1)c1c(C)c3ccccc3nc1n2CCN(C)C)C
  • InChi: 1S/C24H30N4O/c1-17-19-8-6-7-9-21(19)25-24-23(17)20-16-18(29-15-14-27(4)5)10-11-22(20)28(24)13-12-26(2)3/h6-11,16H,12-15H2,1-5H3
  • InChiKey: BMXLSSJVYHSNCS-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Mycobacterium ulcerans flavoprotein disulfide reductase 0.0017 0 0.5
Schistosoma mansoni tar DNA-binding protein 0.0067 0.3494 0.3494
Plasmodium vivax thioredoxin reductase, putative 0.005 0.2299 1
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.005 0.2332 0.2332
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.005 0.2332 0.2332
Schistosoma mansoni tar DNA-binding protein 0.0067 0.3494 0.3494
Plasmodium falciparum thioredoxin reductase 0.005 0.2299 1
Mycobacterium tuberculosis Probable NADH dehydrogenase Ndh 0.0114 0.6806 0.8837
Loa Loa (eye worm) RNA recognition domain-containing protein domain-containing protein 0.0067 0.3494 1
Brugia malayi GTP-binding regulatory protein Gs alpha-S chain, putative 0.005 0.2332 0.6674
Brugia malayi TAR-binding protein 0.0067 0.3494 1
Mycobacterium ulcerans dihydrolipoamide dehydrogenase 0.0017 0 0.5
Plasmodium vivax glutathione reductase, putative 0.005 0.2299 1
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.005 0.2332 0.6674
Mycobacterium tuberculosis Probable dehydrogenase 0.0114 0.6806 0.8837
Mycobacterium tuberculosis Probable oxidoreductase 0.0127 0.7701 1
Mycobacterium tuberculosis Probable membrane NADH dehydrogenase NdhA 0.0114 0.6806 0.8837
Mycobacterium tuberculosis Putative ferredoxin reductase 0.0114 0.6806 0.8837
Echinococcus multilocularis tar DNA binding protein 0.0067 0.3494 1
Mycobacterium leprae DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE 0.0127 0.7701 1
Trichomonas vaginalis glutathione reductase, putative 0.0017 0 0.5
Mycobacterium tuberculosis NAD(P)H quinone reductase LpdA 0.0127 0.7701 1
Brugia malayi RNA binding protein 0.0067 0.3494 1
Mycobacterium tuberculosis NADPH-dependent mycothiol reductase Mtr 0.005 0.2299 0.2985
Brugia malayi glutathione reductase 0.005 0.2299 0.658
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.005 0.2332 0.6674
Mycobacterium tuberculosis Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB 0.0114 0.6806 0.8837
Echinococcus granulosus thioredoxin glutathione reductase 0.005 0.2299 0.658
Brugia malayi RNA recognition motif domain containing protein 0.0067 0.3494 1
Wolbachia endosymbiont of Brugia malayi dihydrolipoamide dehydrogenase E3 component 0.0017 0 0.5
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain 0.005 0.2332 0.0275
Mycobacterium tuberculosis Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras 0.0127 0.7701 1
Wolbachia endosymbiont of Brugia malayi dihydrolipoamide dehydrogenase E3 component 0.0017 0 0.5
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.005 0.2332 0.6674
Loa Loa (eye worm) RNA binding protein 0.0067 0.3494 1
Leishmania major trypanothione reductase 0.005 0.2299 1
Schistosoma mansoni tar DNA-binding protein 0.0067 0.3494 0.3494
Trypanosoma brucei trypanothione reductase 0.005 0.2299 1
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.005 0.2332 0.6674
Giardia lamblia NADH oxidase lateral transfer candidate 0.0017 0 0.5
Mycobacterium tuberculosis Probable reductase 0.0114 0.6806 0.8837
Echinococcus granulosus tar DNA binding protein 0.0067 0.3494 1
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.005 0.2332 0.2332
Mycobacterium ulcerans dihydrolipoamide dehydrogenase, LpdB 0.0017 0 0.5
Plasmodium falciparum glutathione reductase 0.005 0.2299 1
Trypanosoma cruzi trypanothione reductase, putative 0.005 0.2299 1
Echinococcus multilocularis thioredoxin glutathione reductase 0.005 0.2299 0.658
Trichomonas vaginalis mercuric reductase, putative 0.0017 0 0.5
Treponema pallidum NADH oxidase 0.0017 0 0.5
Loa Loa (eye worm) TAR-binding protein 0.0067 0.3494 1
Chlamydia trachomatis dihydrolipoyl dehydrogenase 0.0017 0 0.5
Toxoplasma gondii thioredoxin reductase 0.005 0.2299 1
Brugia malayi Thioredoxin reductase 0.005 0.2299 0.658
Schistosoma mansoni tar DNA-binding protein 0.0067 0.3494 0.3494
Schistosoma mansoni tar DNA-binding protein 0.0067 0.3494 0.3494

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.